Pharma-Bio Serv (PBSV) Total Liabilities (2010 - 2026)

Pharma-Bio Serv (PBSV) has reported Total Liabilities for 17 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities fell 41.29% year-over-year to $1.0 million; the trailing twelve-month figure through Apr 2026 stood at $1.0 million (down 41.29% YoY), and the FY2025 full-year result was $1.7 million, down 32.52% from the prior year.
• Total Liabilities declined to $1.0 million in Q2 2026 per PBSV's latest filing, from $3.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $5.1 million in Q1 2024 and bottomed at $1.0 million in Q2 2026.
• Historically, Total Liabilities has averaged $3.3 million across 5 years, with a median of $3.8 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities tumbled 47.86% in 2022, then gained 29.79% in 2024.
• Over 5 years, Total Liabilities stood at $4.1 million in 2022, then declined by 7.77% to $3.8 million in 2023, then plunged by 31.74% to $2.6 million in 2024, then sank by 32.52% to $1.7 million in 2025, then plunged by 39.89% to $1.0 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $1.0 million, $3.3 million, and $1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.